Nasus Pharma (NASDAQ:NASU) Completes $15M Private Placement for Shares and Warrants

Nasus Pharma (NASDAQ:NASU) closed a private placement on February 11, 2026, raising $15 million by issuing 2.5 million shares of common stock and warrants to subscribe for 1.25 million shares at $6 per share. The proceeds will support the company's ongoing clinical trials and expansion of its U.S. salesforce. The company stated the funding reflects confidence in its lead candidate, NUS-101, a potential treatment for rare genetic disorders.